Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06887049 · ClinicalTrials.gov registry record · NA
Achieving Routine Intervention and Screening for Emotional Health
A NA study of Type 2 Diabetes Mellitus (T2DM) and Diabetes Distress, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 1,250
- Enrollment target
- 1
- Study location
NCT06887049: Recruiting NA study of Type 2 Diabetes Mellitus (T2DM) and Diabetes Distress, sponsored by University of Chicago.
NCT06887049 is a NA study of Type 2 Diabetes Mellitus (T2DM) and Diabetes Distress that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 1,250 participants, above the 470-participant average among 24 other Type 2 Diabetes Mellitus (T2DM) trials with a reported enrollment target (166% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06887049, a NA study of Type 2 Diabetes Mellitus (T2DM) and Diabetes Distress, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,250 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this project is to evaluate the effectiveness of diabetes distress screening and intervention on patients with type 2 diabetes mellitus (T2DM).
Primary Outcome
Rate of A1C from Baseline to follow-up
Conditions Studied
Interventions
- BEHAVIORAL ARISE Learning Community Diabetes Distress Screening and Intervention
- BEHAVIORAL ARISE Enhanced Care brief training
Study Locations (1)
Illinois
- University of Chicago - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,250 participants |
| Start Date | 2026-03-03 |
| Est. Completion | 2028-09 |
| Phase | NA |
What NCT06887049 shows while recruiting
NCT06887049 is an interventional study that assigns participants to a tested intervention. Its 1,250 participants enrollment target places it among the larger protocols in the corpus, above the 470-participant average among 24 other Type 2 Diabetes Mellitus (T2DM) trials with a reported enrollment target (166% higher).
The record links to 2 conditions, with Type 2 Diabetes Mellitus (T2DM) appearing as the primary indexed condition, and to 2 interventions - of which ARISE Learning Community Diabetes Distress Screening and Intervention is the first listed.
NCT06887049 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT06887049 about?
NCT06887049 is a clinical study titled "Achieving Routine Intervention and Screening for Emotional Health". The purpose of this project is to evaluate the effectiveness of diabetes distress screening and intervention on patients with type 2 diabetes mellitus (T2DM).
What is the current status of trial NCT06887049?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,250 participants. The study started on 2026-03-03. Estimated completion is 2028-09.
What conditions does trial NCT06887049 study?
This clinical trial studies the following conditions: Type 2 Diabetes Mellitus (T2DM), Diabetes Distress.
What interventions are being tested in trial NCT06887049?
The interventions under investigation include: ARISE Learning Community Diabetes Distress Screening and Intervention (BEHAVIORAL), ARISE Enhanced Care brief training (BEHAVIORAL).
Who is sponsoring clinical trial NCT06887049?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06887049 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes Mellitus (T2DM)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06887049's enrollment target sits among peer trials
1,250 2nd of 24 the highest of 24 other Type 2 Diabetes Mellitus (T2DM) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Type 2 Diabetes Mellitus (T2DM) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
-
Diabetes Electronic Prompt for Improved Care Coordination and Treatment in the ED
RECRUITING · NA
-
Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge
RECRUITING · NA
-
Diabetes Management Using Continuous Glucose Monitors and Remote Patient Monitoring in Underserved Populations
RECRUITING · NA
-
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
- NCT04670874 · 1,250 participants
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- NCT04807868 · 1,250 participants
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
- NCT05995821 · 1,250 participants
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI